Association between polymorphisms in the FCGRT gene and lupus nephritis in Chinese patients

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 609-614

  Zhou, X J ^a   Yu, L ^a   Zhu, L ^a   Hou, P ^a   Lv, J C ^a   Yu, F ^a   Zhang, Hong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

FCGRT; Lupus nephritis; Variable number of tandem repeats

Indexed keywords

FC RECEPTOR; PROTEIN FCGRT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE AMPLIFICATION; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, FC; TANDEM REPEAT SEQUENCES; YOUNG ADULT;

EID: 70350163828     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. JONSEN A, BENGTSSON AA, NIVED O, TRUEDSSON L, STURFELT G: Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 2007; 40: 613-617
2. ALBA P, BENTO L, CUADRADO MJ et al.: Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003; 62: 556-560
3. GOMEZ-PUERTA JA, BURLINGAME RW, CERVERA R: Anti-chromatin (anti-nucleosome) antibodies: Diagnostic and clinical value. Autoimmun Rev 2008.
4. YUNG S, CHAN TM: Anti-DNA antibodies in the pathogenesis of lupus nephritis - the emerging mechanisms. Autoimmun Rev 2008; 7: 317-321
5. TAKAI T: Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 2005; 25: 1-18. (Pubitemid 40386174)
6. TAKAI T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2: 580-592
7. AKILESH S, PETKOVA S, SPROULE TJ, SHAFFER DJ, CHRISTIANSON GJ, ROOPENIAN D: The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 2004; 113: 1328-1333
8. HE W, LADINSKY MS, HUEY-TUBMAN KE, JENSEN GJ, MCINTOSH JR, BJORKMAN PJ: FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 2008; 455: 542-546
9. CHRISTIANSON GJ, BLANKENBURG RL, DUFFY TM et al.: Beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J Immunol 1996; 156: 4932-4939
10. CHRISTIANSON GJ, BROOKS W, VEKASI S et al.: Beta 2-microglobulin- deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol 1997; 159: 4781-4792
11. ISRAEL EJ, WILSKER DF, HAYES KC, SCHOENFELD D, SIMISTER NE: Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 1996; 89: 573-578
12. MIXTER PF, RUSSELL JQ, DURIE FH, BUDD RC: Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin. J Immunol 1995; 154: 2063-2074
13. OHTEKI T, IWAMOTO M, IZUI S, MACDONALD HR: Reduced development of CD4-8-B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules. Eur J Immunol 1995; 25: 37-41.
14. MATSUMOTO I, STAUB A, BENOIST C, MATHIS D: Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999; 286: 1732-1735
15. SESARMAN A, SITARU AG, OLARU F, ZILLIKENS D, SITARU C: Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita. J Mol Med 2008; 86: 951-959
16. HAYMANN JP, LEVRAUD JP, BOUET S et al.: Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 2000; 11: 632-639
17. AKILESH S, HUBER TB, WU H et al.: Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 2008; 105: 967-972
18. SACHS UJ, SOCHER I, BRAEUNLICH CG, KROLL H, BEIN G, SANTOSO S: A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter. Immunology 2006; 119: 83-89
19. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277 (Pubitemid 13221242)
20. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
21. WEENING JJ, D'AGATI VD, SCHWARTZ MM et al.: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250 (Pubitemid 38140764)
22. WEENING JJ, D'AGATI VD, SCHWARTZ MM et al.: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530 (Pubitemid 38130646)
23. MA YC, ZUO L, CHEN JH et al.: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944 (Pubitemid 44484685)
24. MILLER SA, DYKES DD, POLESKY HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
25. ALARCON-SEGOVIA D, ALARCON-RIQUEL-ME ME, CARDIEL MH et al.: Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005; 52: 1138-1147
26. RHODES B, VYSE TJ: General aspects of the genetics of SLE. Autoimmunity 2007; 40: 550-559
27. SHEN N, TSAO BP: Current advances in the human lupus genetics. Curr Rheumatol Rep 2004; 6: 391-398
28. HARLEY JB, ALARCON-RIQUELME ME, CRISWELL LA et al.: Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-210
29. AKSU K, KITAPCIOGLU G, KESER G et al.: Fc-gamma RIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications? Clin Exp Rheumatol 2008; 26 (Suppl. 50): S77-83.
30. HOSHI D, OKAMOTO H, KANEKO H et al.: Association of a polymorphism in the monocyte chemoattractant protein-1/CCL2 gene and lupus nephritis in systemic lupus erythematosus patients. Clin Exp Rheumatol 2008; 26: 972-973
31. MOSTOWSKA M, WUDARSKI M, CHWALINSKA-SADOWSKA H, JAGODZINSKI PP: The programmed cell death 1 gene 7209 C > T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Clin Exp Rheumatol 2008; 26: 457-460
32. PIOTROWSKI P, LIANERI M, WUDARSKI M, LACKI JK, JAGODZINSKI PP: Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. Clin Exp Rheumatol 2008; 26: 1099-1102
33. KANDIL E, EGASHIRA M, MIYOSHI O, NIIKAWA N, ISHIBASHI T, KASAHARA M: The human gene encoding the heavy chain of the major histocompatibility complex class I-like Fc receptor (FCGRT) maps to 19q13.3. Cytogenet Cell Genet 1996; 73: 97-8.
34. LIU L, GARCIA AM, SANTORO H et al.: Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol 2007; 178: 5390-5398
35. BROWN EE, EDBERG JC, KIMBERLY RP: Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 2007; 40: 567-581